Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
Study of Previously Collected Blood and Tissue Samples From Patients With Nasopharyngeal Carcinoma,Laryngeal Carcinoma and Hypopharyngeal Carcinoma
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The aim of the study is to find for one or more serum or tissue markers of molecular biology in head and neck cancer patients used for early diagnosis, predicting prognosis and being sensitive to chemotherapy and radiotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 27, 2010
CompletedFirst Posted
Study publicly available on registry
July 28, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJuly 28, 2010
March 1, 2009
1.4 years
July 27, 2010
July 27, 2010
Conditions
Keywords
Eligibility Criteria
all of nasopharyngeal carcinoma, hypopharyngeal carcinoma or laryngeal carcinoma visited at ENT department of NanFang hospital
You may qualify if:
- all of nasopharyngeal carcinoma
- hypopharyngeal carcinoma or laryngeal carcinoma visited at ENT department of NanFang hospital
You may not qualify if:
- all of above patients whose anticipated survival duration were less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, Li G, Chen HH, Li XP. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. Int J Oncol. 2014 Apr;44(4):1215-22. doi: 10.3892/ijo.2014.2283. Epub 2014 Jan 28.
PMID: 24481647DERIVED
Biospecimen
blood and tissue samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ping Xiang Li, doctor
E.N.T department of NanFang hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 27, 2010
First Posted
July 28, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2012
Last Updated
July 28, 2010
Record last verified: 2009-03